Pipeline

Pipeline

Utilizing antimicrobial lipids, such as monocaprin and monolaurin and Capretto's proprietary technologies, we are developing medical devices to improving life of those having infections. The projects have passed research work and is now in the development and clinical phases as medical devices. The first clinical trial is expected to be initiated late 2016.